The massive overhaul of Idaho's business and accounting software in 2023 led to errors on financial statements, a legislative ...
Please note the different instructions below for completing a USATF background screen based on whether you are adding a new background screen to the account, you are renewing a preexisting screen, or ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback